RxLink Ginkgo Biloba 120 mg

RxLink Ginkgo Biloba
Standardized Extract 120 mg
DESCRIPTION
RxLink Ginkgo Biloba contains 120 mg of the herb Ginkgo
biloba, in a vegetarian capsule. The active ingredients, ginkgo
f
lavone glycosides, can help protect the body’s structure
and function against damage from free radicals, as well as
helping to maintain healthy circulatory function and mental
performance.
FUNCTIONS
RxLink Ginkgo biloba is the oldest living species of tree, having
survived relatively unchanged for at least 200 million years.
Native to China, ginkgo has long been recommended in
Chinese herbal medicine for its numerous nutritional benefits
for the brain and circulatory system. Ginkgo leaf extract
has been the object of numerous scientific and clinical
studies since the early 1970s and is now probably the most
extensively studied and utilized botanical extract in the world.
Interest in Ginkgo biloba centers on its reputed benefits on
brain function, especially on the aging brain. With advancing
age, the body often suffers from decreased blood vessel
elasticity and tone, and decreased blood fluidity. Insufficient
blood, oxygen, and nutrient flow to the brain can lead to
impairment in cognitive function. Studies over the past 30
years show that 120 to 240 mg per day of Ginkgo biloba
extract increases blood flow to the brain resulting in increased
oxygen and glucose utilization with subsequent improvement
in mental function. These benefits are attributed to two main
classes of phytoactive compounds present in the Ginkgo
biloba leaf: ginkgo flavone glycosides and terpene lactones.
As powerful antioxidants, the ginkgo flavone glycosides
counteract the deleterious actions of free radical accumulation
which impairs cellular energy production, nerve transmission,
and increases vascular rigidity. Ginkgo biloba extract is also
reported to inhibit the tendency of red blood cells to stick
together (“clumping”), thereby enhancing the fluidity of the
blood. Taken together, these actions contribute significantly to
increasing blood flow to the brain.
INDICATIONS
RxLink Ginkgo Biloba may be a useful dietary supplement for
individuals who are concerned about their mental function and
wish to obtain the benefits of this well-documented herb.
FORMULA (RxLink Ginkgo Biloba)
1 Vegetarian Capsule Contains:
Ginkgo biloba Leaf Extract 50:1 ……………………. 120 mg
(Standardized to: 24% [28.8 mg] Flavoneglycosides,
6% [7.2 mg] Terpene Lactones and 0.8% [0.96 mg]
Ginkgolide B)
Other Ingredients: capsule (cellulose and water), rice powder,
magnesium stearate, and silica
This product contains NO added sugar, salt, dairy, yeast,
wheat, gluten, corn, soy, preservatives, artificial colors or
flavors.
SUGGESTED USE
As a dietary supplement, adults take one (1) vegetarian
capsule daily with meals, or as directed by a healthcare
professional.
SIDE EFFECTS
No adverse effects have been reported.
STORAGE
Store in a cool, dry place, away from direct light. Keep out of
reach of children.
REFERENCES
Clostre F. [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn
of the year 2000]. Ann Pharm Fr 1999;57 Suppl 1:1S8-88.
Droy-Lefaix MT, Cluzel J, Menerath JM, Bonhomme B, Doly M. Antioxidant
effect of a Ginkgo biloba extract (EGb 761) on the retina. Int J Tissue React
1995;17:93-100.
Dziak LA, Golik VA. [The efficacy of treating cerebral ischemia due to
changes in the major cerebral arteries by using the preparation Tanakan (EGB
761)]. Lik Sprava 1998;125-7.
Haase J, Halama P, Horr R. [Effectiveness of brief infusions with Ginkgo
biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer
type]. Z Gerontol Geriatr 1996;29:302-9.
Itil TM, Eralp E, Ahmed I, Kunitz A, Itil KZ. The pharmacological effects of
ginkgo biloba, a plant extract, on the brain of dementia patients in comparison
with tacrine. Psychopharmacol Bull 1998;34:391-7.
Ivaniv OP. [The results of using different forms of a Ginkgo biloba
extract (EGb 761) in the combined treatment of patients with circulatory
encephalopathy]. Lik Sprava 1998;123-8.
Janssens D, Michiels C, Delaive E, Eliaers F, Drieu K, Remacle J. Protection
of hypoxia-induced ATP decrease in endothelial cells by ginkgo biloba extract
and bilobalide. Biochem Pharmacol 1995;50:991-9.
Kanowski S, Herrmann WM, Stephan K, Wierich W, Horr R. Proof of efficacy
of the ginkgo biloba special extract EGb 761 in outpatients suffering from
mild to moderate primary degenerative dementia of the Alzheimer type or
multi-infarct dementia. Pharmacopsychiatry 1996;29:47-56.
Kidd PM. A review of nutrients and botanicals in the integrative management
of cognitive dysfunction. Altern Med Rev 1999;4:144-61.
Klein J, Chatterjee SS, Loffelholz K. Phospholipid breakdown and choline
release under hypoxic conditions: inhibition by bilobalide, a constituent of
Ginkgo biloba. Brain Res 1997;755:347-50.
Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF.
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo
biloba for dementia. North American EGb Study Group [see comments]. Jama
1997;278:1327-32.
Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on
cognitive function in Alzheimer disease. Arch Neurol 1998;55:1409-15.
Oyama Y, Chikahisa L, Ueha T, Kanemaru K, Noda K. Ginkgo biloba extract
protects brain neurons against oxidative stress induced by hydrogen peroxide.
Brain Res 1996;712:349-52.
Perry EK, Pickering AT, Wang WW, Houghton P, Perry NS. Medicinal plants
and Alzheimer’s disease: Integrating ethnobotanical and contemporary
scientific evidence. J Altern Complement Med 1998;4:419-28.
Perry EK, Pickering AT, Wang WW, Houghton PJ, Perry NS. Medicinal
plants and Alzheimer’s disease: from ethnobotany to phytotherapy. J Pharm
Pharmacol 1999;51:527-34.
Pietri S, Maurelli E, Drieu K, Culcasi M. Cardioprotective and anti-oxidant
effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J
Mol Cell Cardiol 1997;29:733-42.
Pietri S, Seguin JR, d’Arbigny P, Drieu K, Culcasi M. Ginkgo biloba extract
(EGb 761) pretreatment limits free radical- induced oxidative stress in patients
undergoing coronary bypass surgery. Cardiovasc Drugs Ther 1997;11:121-31.
Pitchumoni SS, Doraiswamy PM. Current status of antioxidant therapy for
Alzheimer’s Disease. J Am Geriatr Soc 1998;46:1566-72.
Riedel WJ, Jorissen BL. Nutrients, age and cognitive function [In Process
Citation]. Curr Opin Clin Nutr Metab Care 1998;1:579-85.
Rigney U, Kimber S, Hindmarch I. The effects of acute doses of standardized
Ginkgo biloba extract on memory and psychomotor performance in
volunteers. Phytother Res 1999;13:408-15.
Rong Y, Geng Z, Lau BH. Ginkgo biloba attenuates oxidative stress in
macrophages and endothelial cells. Free Radic Biol Med 1996;20:121-7.
Smith PF, Maclennan K, Darlington CL. The neuroprotective properties of the
Ginkgo biloba leaf: a review of the possible relationship to platelet-activating
factor (PAF). J Ethnopharmacol 1996;50:131-9.
Soholm B. Clinical improvement of memory and other cognitive functions by
Ginkgo biloba: review of relevant literature. Adv Ther 1998;15:54-65.
Stoll S, Scheuer K, Pohl O, Muller WE. Ginkgo biloba extract (EGb 761)
independently improves changes in passive avoidance learning and brain
membrane fluidity in the aging mouse. Pharmacopsychiatry 1996;29:144-9.
Wesnes KA, Faleni RA, Hefting NR, Hoogsteen G, Houben JJ, Jenkins E,
Jonkman JH, Leonard J, Petrini O, van Lier JJ. The cognitive, subjective,
and physical effects of a ginkgo biloba/panax ginseng combination in healthy
volunteers with neurasthenic complaints. Psychopharmacol Bull 1997;33:677
83.
Winter JC. The effects of an extract of Ginkgo biloba, EGb 761, on cognitive
behavior and longevity in the rat. Physiol Behav 1998;63:425-33.
These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure, or
prevent any disease.
Manufactured For:
RxLink Pharmaceuticals
Appleton, WI  54912